APA (7th ed.) Citation

Pampusch, M. S., Abdelaal, H. M., Cartwright, E. K., Molden, J. S., Davey, B. C., Sauve, J. D., . . . Skinner, P. J. (2022). CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection. PLoS Pathogens, 18(2), 1. https://doi.org/10.1371/journal.ppat.1009831

Chicago Style (17th ed.) Citation

Pampusch, Mary S., et al. "CAR/CXCR5-T Cell Immunotherapy Is Safe and Potentially Efficacious in Promoting Sustained Remission of SIV Infection." PLoS Pathogens 18, no. 2 (2022): 1. https://doi.org/10.1371/journal.ppat.1009831.

MLA (9th ed.) Citation

Pampusch, Mary S., et al. "CAR/CXCR5-T Cell Immunotherapy Is Safe and Potentially Efficacious in Promoting Sustained Remission of SIV Infection." PLoS Pathogens, vol. 18, no. 2, 2022, p. 1, https://doi.org/10.1371/journal.ppat.1009831.